OUTLOOK THERAPEUTICS INCOUTLOOK THERAPEUTICS INCOUTLOOK THERAPEUTICS INC

OUTLOOK THERAPEUTICS INC

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
−0.84EUR
Revenue estimate
Market capitalization
‪171.09 M‬EUR
−3.61EUR
‪−55.80 M‬EUR
‪15.25 M‬
Beta (1Y)
−1.35

About Outlook Therapeutics, Inc.

CEO
C. Russell Trenary
Headquarters
Iselin
Employees (FY)
24
Founded
2010
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 41O is 8.00 EUR — it has increased by 0.63% in the past 24 hours. Watch OUTLOOK THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange OUTLOOK THERAPEUTICS INC stocks are traded under the ticker 41O.
OUTLOOK THERAPEUTICS INC is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
41O stock is 2.52% volatile and has beta coefficient of −1.35. Track OUTLOOK THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is OUTLOOK THERAPEUTICS INC there?
41O earnings for the last quarter are −0.95 EUR per share, whereas the estimation was −1.09 EUR resulting in a 13.04% surprise. The estimated earnings for the next quarter are −0.90 EUR per share. See more details about OUTLOOK THERAPEUTICS INC earnings.
Yes, you can track OUTLOOK THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
41O stock has risen by 4.64% compared to the previous week, the month change is a 11.89% fall, over the last year OUTLOOK THERAPEUTICS INC has showed a 2.64% increase.
41O net income for the last quarter is ‪−10.13 M‬ EUR, while the quarter before that showed ‪−12.29 M‬ EUR of net income which accounts for 17.59% change. Track more OUTLOOK THERAPEUTICS INC financial stats to get the full picture.
Today OUTLOOK THERAPEUTICS INC has the market capitalization of ‪171.09 M‬, it has decreased by 1.60% over the last week.
No, 41O doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 41O shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OUTLOOK THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
41O reached its all-time high on Mar 28, 2024 with the price of 11.66 EUR, and its all-time low was 6.39 EUR and was reached on Mar 20, 2024. View more price dynamics on 41O chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has 24.00 employees. See our rating of the largest employees — is OUTLOOK THERAPEUTICS INC on this list?
We've gathered analysts' opinions on OUTLOOK THERAPEUTICS INC future price: according to them, 41O price has a max estimate of 55.97 EUR and a min estimate of 23.32 EUR. Watch 41O chart and read a more detailed OUTLOOK THERAPEUTICS INC stock forecast: see what analysts think of OUTLOOK THERAPEUTICS INC and suggest that you do with its stocks.